Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIMOGENE LAHERPAREPVEC vs TAPENTADOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIMOGENE LAHERPAREPVEC vs TAPENTADOL: Safety Overview

Metric TALIMOGENE LAHERPAREPVEC TAPENTADOL
Total FAERS Reports 1,475 29,208
Deaths Reported 164 20,205
Death Rate 11.1% 69.2%
Hospitalizations 286 3,304
Average Patient Age 66.7 yrs 58.0 yrs
% Female Patients 48.3% 60.1%
FDA Approval Date N/A Aug 25, 2011
Manufacturer Amgen Inc Collegium Pharmaceutical, Inc.
Route INTRALESIONAL ORAL
Marketing Status N/A Prescription